CD44 and breast carcinoma: In agreement with our data, Tan et al. described in detail previously [12] that PLK1 inhibition in highly invasive breast cancer MDA-MB-231 cells resulted in depletion of CSC-like CD44+/CD24−/low populations and accordingly significantly reduced tumorsphere formation.